Cargando…
Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
Between 2005 and 2021, 49 cases of classical congenital adrenal hyperplasia were diagnosed in New Zealand, 39 were detected in newborns and 10 were not detected by screening. For every case of CAH detected by screening, 10 false-positive tests are encountered. Second-tier liquid chromatography-tande...
Autores principales: | de Hora, Mark R., Heather, Natasha L., Webster, Dianne R., Albert, Benjamin B., Hofman, Paul L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590017/ https://www.ncbi.nlm.nih.gov/pubmed/36278626 http://dx.doi.org/10.3390/ijns8040056 |
Ejemplares similares
-
The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives
por: de Hora, Mark, et al.
Publicado: (2023) -
Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2020) -
Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience
por: Heather, Natasha, et al.
Publicado: (2022) -
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
por: Held, Patrice K., et al.
Publicado: (2020) -
Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016)